news

Asthma medicine halves risk of Parkinson’s

7
SHARES

Researchers have found that asthma medicine can halve a patient’s risk of developing Parkinson’s disease…

medicine

Using data gathered from 100 million prescriptions, researchers at the University of Bergen (UiB) have found that asthma medicine can halve a patient’s risk of developing Parkinson’s disease

 

ACCESS your FREE COPY

 


This report addresses the key factors shaping pharmaceutical formulation, including regulation, QC and analysis.

Access the full report now to discover the techniques, tools and innovations that are transforming pharmaceutical formulation, and learn how to position your organisation for long-term success.

What you’ll discover:

  • Key trends shaping the pharmaceutical formulation sector
  • Innovations leading progress in pharmaceutical formulation and how senior professionals can harness their benefits
  • Considerations and best practices when utilising QbD during formulation of oral solid dosage forms
  • And more!

Don’t miss your chance to access this exclusive report ! Access now – it’s free

By studying the effect of 1000 medicines, researchers discovered that medicine against asthma and blood pressure is linked to the risk of getting Parkinson´s disease.

While the use of asthma medicine halves the risk of getting Parkinson´s, one type of medicine against high blood pressure doubles the risk.

These discoveries could be the start of a radically new treatment of Parkinson´s patients.

Researchers at the Department of Global Public Health and Primary Care (IGS) at UiB have completed a large study that included data from the Norwegian Prescription Database, in cooperation with researchers at Harvard University.

“Our analysis of data from the whole Norwegian population has been decisive for the conclusion in this study,” says Professor Trond Riise at IGS. He leads the registry study in Norway.

Prof Riise and his colleagues have analysed more than 100 million Norwegian prescriptions registered since 2004.In the study, the treatment of Parkinson´s was linked to prescriptions of asthma medicine and the medicine for high blood pressure. It enabled the researchers to see the connection between medicine use and illness.

The UiB-researchers were able to make these comparisons by using the prescription database. The Norwegian analysis was carried out after researchers at Harvard University found these effects of the medicines in animal tests and in experiments with brain cells in the lab. Their results showed that these different medicines had opposite effects on the risk of Parkinson´s.

Parkinson´s disease is a chronic disease with unknown causes. The disease destroys the brain cells that control body movements. Shivering, stiff arms and legs and poor coordination are typical symptoms of Parkinson´s. The symptoms may develop slowly, and it sometimes takes time to make a correct diagnosis.

Leave a Reply

Your email address will not be published. Required fields are marked *

Share via
Share via